A 10-year NHS-led study has found that focal therapy can [...]

Medicus Pharma has received positive feedback from FDA and central [...]

Compass Pathways has published a post hoc analysis of its [...]

Rani Therapeutics has reported positive initial Phase 1a data for [...]

Adneuris Therapeutics has granted Zhejiang Conba Pharmaceutical exclusive rights to [...]

Fractyl Health has reported positive one-year data from the midpoint [...]

The European Commission has approved Erbitux (cetuximab) in combination with [...]

The US FDA has granted Fast Track Designation to SOTIO [...]

Skyhawk Therapeutics has expanded its global pivotal Phase 2/3 clinical [...]

ProMIS Neurosciences has reported the first human evidence that its [...]